Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hyperlipoproteinemias

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 37 articles:
HTML format
Text format



Single Articles


    March 2017
  1. PEREZ DE ISLA L, Alonso R, Mata N, Fernandez-Perez C, et al
    Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry.
    Circulation. 2017 Mar 8. pii: CIRCULATIONAHA.116.024541.
    PubMed     Text format     Abstract available


    November 2016
  2. MAHMOODI BK, Cushman M, Naess IA, Allison MA, et al
    Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies.
    Circulation. 2016 Nov 9. pii: CIRCULATIONAHA.116.024507.
    PubMed     Text format     Abstract available


  3. DE FERRANTI S, Sheldrick RC, Wong JB
    Response by de Ferranti et al to Letter Regarding Article, "Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)".
    Circulation. 2016;134:e395-e396.
    PubMed     Text format    


  4. PEREZ DE ISLA L, Saltijeral Cerezo A, Mata P
    Letter by Perez de Isla et al Regarding Article, "Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)".
    Circulation. 2016;134:e393-e394.
    PubMed     Text format    


    October 2016
  5. BOZKURT B, Aguilar D, Deswal A, Dunbar SB, et al
    Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2016 Oct 31. pii: CIR.0000000000000450.
    PubMed     Text format    


    September 2016
  6. HOVINGH GK, Kastelein JJ
    Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too Little.
    Circulation. 2016;134:710-2.
    PubMed     Text format    


    July 2016
  7. NANCHEN D, Gencer B, Muller O, Auer R, et al
    Prognosis of Patients with Familial Hypercholesterolemia After Acute Coronary Syndromes.
    Circulation. 2016 Jul 26. pii: CIRCULATIONAHA.116.023007.
    PubMed     Text format     Abstract available


  8. TANG SY, Monslow J, R Grant G, Todd L, et al
    Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice.
    Circulation. 2016;134:328-38.
    PubMed     Text format     Abstract available


  9. CHOMISTEK AK, Henschel B, Eliassen AH, Mukamal KJ, et al
    Frequency, Type, and Volume of Leisure-Time Physical Activity and Risk of Coronary Heart Disease in Young Women.
    Circulation. 2016;134:290-9.
    PubMed     Text format     Abstract available


  10. PATON DM
    Letter by Paton Regarding Article, "Knowing the Prevalence of Familial Hypercholesterolemia Matters".
    Circulation. 2016;134:e17-8.
    PubMed     Text format    


  11. HAAS ME, Levenson AE, Sun X, Liao WH, et al
    The Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Nephrotic Syndrome-Associated Hypercholesterolemia.
    Circulation. 2016;134:61-72.
    PubMed     Text format     Abstract available


  12. PERAK AM, Ning H, de Ferranti SD, Gooding HC, et al
    Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.
    Circulation. 2016;134:9-19.
    PubMed     Text format     Abstract available


  13. RODRIGUEZ F, Knowles JW
    Enough Evidence, Time to Act!
    Circulation. 2016;134:20-3.
    PubMed     Text format    


    April 2016
  14. ONORATO A, Sturm AC
    Heterozygous Familial Hypercholesterolemia.
    Circulation. 2016;133:e587-9.
    PubMed     Text format    


    March 2016
  15. DE FERRANTI SD, Rodday AM, Mendelson MM, Wong JB, et al
    Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES).
    Circulation. 2016;133:1067-72.
    PubMed     Text format     Abstract available


  16. GOLDBERG AC, Gidding SS
    Knowing the Prevalence of Familial Hypercholesterolemia Matters.
    Circulation. 2016;133:1054-7.
    PubMed     Text format    


  17. KOENE RJ, Prizment AE, Blaes A, Konety SH, et al
    Shared Risk Factors in Cardiovascular Disease and Cancer.
    Circulation. 2016;133:1104-14.
    PubMed     Text format     Abstract available


  18. FORD I, Murray H, McCowan C, Packard CJ, et al
    Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study.
    Circulation. 2016;133:1073-80.
    PubMed     Text format     Abstract available


    November 2015
  19. GUAN J, Khambhati J, Jones LW, Morgans A, et al
    Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis.
    Circulation. 2015;132:e218-20.
    PubMed     Text format    


    October 2015
  20. GIDDING SS, Ann Champagne M, de Ferranti SD, Defesche J, et al
    The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association.
    Circulation. 2015 Oct 28. pii: CIR.0000000000000297.
    PubMed     Text format    


  21. DHANESHA N, Ahmad A, Prakash P, Doddapattar P, et al
    Genetic Ablation of Extra Domain A of Fibronectin in Hypercholesterolemic Mice Improves Stroke Outcome by Reducing Thrombo-Inflammation.
    Circulation. 2015 Oct 27. pii: CIRCULATIONAHA.115.016540.
    PubMed     Text format     Abstract available


  22. BERGERON N, Phan BA, Ding Y, Fong A, et al
    Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition: A New Therapeutic Mechanism for Reducing Cardiovascular Disease Risk.
    Circulation. 2015;132:1648-66.
    PubMed     Text format     Abstract available


  23. KIM JB, Kim K, Lindsay ME, MacGillivray T, et al
    Risk of rupture or dissection in descending thoracic aortic aneurysm.
    Circulation. 2015;132:1620-9.
    PubMed     Text format     Abstract available


  24. MESSINA LM
    Toward a Biologic Therapy to Improve Stroke Outcomes After Thrombolytic Therapy.
    Circulation. 2015 Oct 27. pii: CIRCULATIONAHA.115.019446.
    PubMed     Text format     Abstract available


  25. NAVAR-BOGGAN AM, Peterson ED, D'Agostino RB Sr, Neely B, et al
    Response to Letter Regarding Article, "Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease".
    Circulation. 2015;132:e203.
    PubMed     Text format    


  26. HAYWARD RA
    Letter by Hayward Regarding Article, "Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease".
    Circulation. 2015;132:e202.
    PubMed     Text format    


    September 2015
  27. WHITE JR, Chang CH, So-Armah KA, Stewart JC, et al
    Depression and HIV Infection are Risk Factors for Incident Heart Failure Among Veterans: Veterans Aging Cohort Study.
    Circulation. 2015 Sep 10. pii: CIRCULATIONAHA.114.014443.
    PubMed     Text format     Abstract available


    August 2015
  28. ABRAHAM TM, Pedley A, Massaro JM, Hoffman U, et al
    Association Between Visceral and Subcutaneous Adipose Depots and Incident Cardiovascular Disease Risk Factors.
    Circulation. 2015 Aug 20. pii: CIRCULATIONAHA.114.015000.
    PubMed     Text format     Abstract available


    July 2015
  29. PEDRIGI RM, Poulsen CB, Mehta VV, Holm NR, et al
    Inducing Persistent Flow Disturbances Accelerates Atherogenesis and Promotes Thin Cap Fibroatheroma Development in D374Y-PCSK9 Hypercholesterolemic Minipigs.
    Circulation. 2015 Jul 15. pii: CIRCULATIONAHA.115.016270.
    PubMed     Text format     Abstract available


    June 2015
  30. CHANG CH, Lin CH, Caffrey JL, Lee YC, et al
    Risk of Intracranial Hemorrhage From Statin Use in Asians: A Nationwide Cohort Study.
    Circulation. 2015;131:2070-8.
    PubMed     Text format     Abstract available


    May 2015
  31. LIN Z, Pan X, Wu F, Ye D, et al
    Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.
    Circulation. 2015;131:1861-71.
    PubMed     Text format     Abstract available


  32. KASAMATSU A, Takaya T, Mori S, Kashio K, et al
    Reconstruction of an extracardiac aortocoronary collateral and simulation of selective angiography with multidetector-row computed tomography.
    Circulation. 2015;131:e476-9.
    PubMed     Text format    


  33. FOX CS, Hall JL, Arnett DK, Ashley EA, et al
    Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association.
    Circulation. 2015;131:1715-36.
    PubMed     Text format     Abstract available


  34. RASHID S, Tavori H, Brown PE, Linton MF, et al
    Response to letter regarding article, "Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechani
    Circulation. 2015;131:e428.
    PubMed     Text format    


  35. LE MAY C, Cariou B
    Letter from Le May and Cariou regarding article, "Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independ
    Circulation. 2015;131:e427.
    PubMed     Text format    


    March 2015
  36. FITCHETT DH, Hegele RA, Verma S
    Cardiology patient page. Statin intolerance.
    Circulation. 2015;131:e389-91.
    PubMed     Text format    


  37. BAUER RC, Tohyama J, Cui J, Cheng L, et al
    Knockout of Adamts7, a novel coronary artery disease locus in humans, reduces atherosclerosis in mice.
    Circulation. 2015;131:1202-13.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: